Researchers from the Higher Council for Scientific Research (CSIC in Spanish) have identified and characterized a new class of antivirals against SARS-CoV-2 that act by blocking the entry of the virus into the host cell through its interaction with the 'spike' protein (S protein).
The work has been…
Read More...
